Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises KEYTO Group in connection with the acquisition of Hemfixarna
Mandate

Vinge advises KEYTO Group in connection with the acquisition of Hemfixarna

January 29, 2026 M&A Employment and Benefits Intellectual Property Commercial Agreements Data protection and processing of personal data

KEYTO Group continues its growth journey by strengthening its offering in Sweden as Hemfixarna Nordic AB joins KEYTO Group.

Vinges team mainly consisted of Jonas Bergström, Gustav Wahlberg and Ian Linde (M&A), William Karo Persson (Employment), Ian Jonsson and Filippa Eriksson (IP), Hedvig Ekdahl and Avidh Tajik (Commercial Agreements), Elis Allmark and Katja Häglund (IT & GDPR) as well as Filippa Bergkvist (Transaction Support).

Read the clients press release here.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026